IDEXX Labs (IDXX) Tops Q2 EPS by 12c; Raises Outlook

Go back to IDEXX Labs (IDXX) Tops Q2 EPS by 12c; Raises Outlook

Northcoast Research Upgrades IDEXX Laboratories (IDXX) to Neutral

August 3, 2016 9:32 AM EDT

Northcoast Research upgraded IDEXX Laboratories (NASDAQ: IDXX) from Sell to Neutral.

For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.

Shares of IDEXX Laboratories closed at $105.88 yesterday.

... More

IDEXX Laboratories (IDXX) PT Raised to $120 at Stifel on 'Very Impressive' Q2

August 2, 2016 1:26 PM EDT

Stifel Buy analyst Jonathan Block reiterated a Buy rating and raised his price target on IDEXX Laboratories (NASDAQ: IDXX) to $120.00 (from $92.00) following "very impressive" 2Q16 results with revenue of $467MM and EPS of $0.74, well above our $447MM and $0.61 estimates.

Block commented, "Management raised 2016... More